Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $114M | $122M | $132M | $138M | $119M | $179M | $171M | $154M | $114M | $130M |
| Revenue growth | — | 6.8% | 8.6% | 4.4% | -14.0% | 50.2% | -4.2% | -9.9% | -26.1% | 14.1% |
| Gross profit | $25.3M | $26.2M | $26.3M | $23.6M | $18.9M | $30.4M | $30.5M | $18.2M | $6.87M | $9.29M |
| Gross margin | 22.1% | 21.5% | 19.9% | 17.0% | 15.9% | 17.1% | 17.8% | 11.8% | 6.0% | 7.2% |
| Operating income | $12.3M | $9.70M | $9.53M | $5.96M | -$1.51M | $13.7M | $13.7M | $4.71M | -$8.53M | -$8.66M |
| Operating margin | 10.7% | 8.0% | 7.2% | 4.3% | -1.3% | 7.7% | 8.0% | 3.1% | -7.5% | -6.7% |
| Net income | $9.55M | $7.24M | $5.05M | $6.54M | -$1.65M | $10.8M | $10.7M | $2.52M | -$7.22M | -$13.6M |
| Net margin | 8.4% | 5.9% | 3.8% | 4.7% | -1.4% | 6.0% | 6.3% | 1.6% | -6.3% | -10.5% |
| EPS (diluted) | $1.44 | $1.09 | $0.73 | $0.92 | -$0.25 | $1.69 | $1.74 | $0.43 | -$1.23 | -$2.28 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $9.29M | $14.1M | $1.83M | $6.56M | $3.69M | $20.8M | $11.9M | $7.02M | -$1.50M | $5.93M |
| Capital expenditures | $10.4M | $5.35M | $4.08M | $5.33M | $4.54M | $5.11M | $26.5M | $13.5M | $3.02M | $3.61M |
| Free cash flow | -$1.16M | $8.78M | -$2.25M | $1.24M | -$850K | $15.7M | -$14.6M | -$6.50M | -$4.51M | $2.32M |
| Share buybacks | $648K | $712K | $510K | $1.37M | $3.75M | $4.15M | $5.50M | $1.50M | $221K | $178K |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $19.7M | $27.8M | $23.6M | $25.0M | $30.5M | $32.1M | $21.8M | $13.6M | $12.0M | $12.3M |
| Total assets | $74.2M | $72.6M | $85.2M | $93.5M | $120M | $120M | $146M | $134M | $162M | $152M |
| Total liabilities | $20.4M | $11.5M | $17.0M | $17.4M | $48.8M | $40.2M | $57.5M | $45.4M | $79.7M | $83.5M |
| Long-term debt | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |
| Shareholders' equity | $53.7M | $61.1M | $68.2M | $76.1M | $71.4M | $80.1M | $88.5M | $88.8M | $82.6M | $68.4M |
| Retained earnings | $38.6M | $45.8M | $50.8M | $57.4M | $56.2M | $66.9M | $77.7M | $80.2M | $73.0M | $59.4M |
| Shares (wtd avg diluted) | 6.64M | 6.66M | 6.89M | 7.10M | 6.70M | 6.38M | 6.16M | 5.88M | 5.87M | 5.95M |
Every figure is extracted from NATURAL ALTERNATIVES INTERNATIONAL INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.